{
  "trial_id": "NCT02599090",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Histopathologically proven diagnosis of glioblastoma or gliosarcoma.",
      "label": "not_met",
      "evidence": "The patient has a history of anaplastic astrocytoma, not glioblastoma or gliosarcoma."
    },
    {
      "criterion": "At least 1 block of tumor tissue available for submission to the central pathologist.",
      "label": "unknown",
      "evidence": "The patient's text does not mention availability of tumor tissue blocks."
    },
    {
      "criterion": "Diagnosis must be established by open biopsy or tumor resection.",
      "label": "met",
      "evidence": "The patient had a biopsy and tumor resection, so this criterion is met."
    },
    {
      "criterion": "The tumor must have a supratentorial component.",
      "label": "unknown",
      "evidence": "The patient's text does not mention the location of the tumor within the brain."
    },
    {
      "criterion": "Patients must have recovered from the effects of surgery, postoperative infection, and other complications before study registration.",
      "label": "met",
      "evidence": "The patient had radiation therapy 11 cycles ago, so it is likely they have recovered from surgery."
    },
    {
      "criterion": "All patients must sign an informed consent indicating that they are aware of the investigational nature of this study.",
      "label": "unknown",
      "evidence": "The patient's text does not mention informed consent."
    },
    {
      "criterion": "A diagnostic contrast-enhanced MRI or CT scan (if MRI is contraindicated) of the brain must be performed postoperatively in the period between surgery and initiation of radiation therapy.",
      "label": "unknown",
      "evidence": "The patient's text does not mention a recent brain imaging study."
    },
    {
      "criterion": "Therapy must begin \u22645 weeks after the most recent brain tumor surgery.",
      "label": "met",
      "evidence": "The patient had radiation therapy 11 cycles ago, so it is likely they started within 5 weeks of surgery."
    },
    {
      "criterion": "History/physical examination within 14 days prior to study registration.",
      "label": "unknown",
      "evidence": "The patient's text does not mention a recent history and physical examination."
    },
    {
      "criterion": "Neurologic examination within 14 days prior to study registration.",
      "label": "unknown",
      "evidence": "The patient's text does not mention a recent neurologic examination."
    },
    {
      "criterion": "Documentation of steroid doses within 14 days prior to study registration and stable or decreasing steroid dose within 5 days prior to registration.",
      "label": "met",
      "evidence": "The patient was on high-dose steroids, but the text does not mention recent documentation."
    },
    {
      "criterion": "Karnofsky performance status of \u226560.",
      "label": "unknown",
      "evidence": "The patient's text does not mention their Karnofsky score."
    },
    {
      "criterion": "Age \u226518 years.",
      "label": "met",
      "evidence": "The patient is 45 years old, so this criterion is met."
    }
  ],
  "exclusion": [
    {
      "criterion": "Prior invasive malignancy (except for non-melanomatous skin cancer) unless disease-free for \u22653 years.",
      "label": "triggers",
      "evidence": "The patient has a history of anaplastic astrocytoma, which is a prior invasive malignancy."
    },
    {
      "criterion": "Recurrent or multifocal malignant gliomas.",
      "label": "unknown",
      "evidence": "The patient's text does not mention recurrent or multifocal disease."
    },
    {
      "criterion": "Metastases detected below the tentorium or beyond the cranial vault.",
      "label": "unknown",
      "evidence": "The patient's text does not mention metastatic disease outside of the brain."
    },
    {
      "criterion": "Prior chemotherapy or radiosensitizers for cancers of the head and neck region; note that prior chemotherapy for a different cancer is allowable.",
      "label": "unknown",
      "evidence": "The patient's text does not mention prior chemotherapy or radiosensitizers."
    },
    {
      "criterion": "Prior use of Gliadel wafers or any other intratumoral or intracavitary treatment are not permitted.",
      "label": "unknown",
      "evidence": "The patient's text does not mention Gliadel wafers or other treatments."
    },
    {
      "criterion": "Prior radiotherapy to the head or neck (except for T1 glottic cancer), resulting in overlap of radiation fields.",
      "label": "unknown",
      "evidence": "The patient's text does not mention prior radiotherapy to the head or neck."
    },
    {
      "criterion": "Severe, active co-morbidity, defined as follows: Cardiac disease - Congestive heart failure > class II New York Heart Association (NYHA).",
      "label": "unknown",
      "evidence": "The patient's text does not mention cardiac disease or congestive heart failure."
    },
    {
      "criterion": "Uncontrolled hypertension defined as systolic blood pressure > 140 mmHg or diastolic pressure > 90 mmHg, despite optimal medical management.",
      "label": "triggers",
      "evidence": "The patient has hypertension, which is not well-controlled."
    }
  ],
  "notes": "The patient's history of anaplastic astrocytoma and uncontrolled hypertension make them likely ineligible for this trial. However, the availability of tumor tissue blocks and recent brain imaging studies are unknown, so further investigation would be needed to confirm eligibility.",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT02599090",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b"
  }
}